We scan new podcasts and send you the top 5 insights daily.
A former CFO reveals that the extensive internal preparation for quarterly earnings calls—often over 100 hours—provides little value for smaller biotechs with minimal updates. He advises them to redirect those resources toward more impactful activities.
According to research cited by Eric Ries, mandatory quarterly reporting causes a ~5% loss in total equity value. The frequent reporting cycle incentivizes leadership to manage for the report itself—generating short-term metrics for Wall Street—rather than focusing on long-term product and business health.
The default rush to hire a C-suite is often a mistake. Luba Greenwood argues that a full-time CFO is an expensive and frequently unnecessary hire for an early-stage company. The role is only critical for complex, multi-asset companies or those actively pursuing an IPO.
The common practice of manually exporting massive datasets into Excel for quarterly business reviews is a reactive "fire drill." It's an exhaustive, painful exercise that often crashes systems and consumes weeks of effort, only to produce rearview-mirror insights that are too late to influence the outcome.
Instead of presenting information that can be read in an email, a successful founder sent updates beforehand. This freed up meeting time for strategic discussions on product, capital, and hiring, which accelerated the company's growth.
The transition from academic scientist to biotech CEO involves a critical mindset shift. In academia, ideas and knowledge are the primary capital. In the resource-intensive biotech world, time is the scarcest and most valuable asset, demanding parallel execution.
Post-IPO, credibility is a biotech's most valuable asset. Leaders should "under-promise and over-perform" by avoiding specific quarterly guidance for clinical milestones. Instead, use broader windows like "first half of the year" to build in flexibility, as clinical trials rarely run on a perfect schedule.
Adopt the private equity board meeting model: circulate a detailed brief a week in advance. This forces attendees to consume updates asynchronously. The meeting itself can then be dedicated entirely to debating critical, forward-looking decisions instead of wasting time on status reports.
Instead of scrambling before a sale, treat exit preparation as a recurring quarterly task. After closing the books, spend a few days updating the data room and quality of earnings materials. This reduces the heavy lift during a live deal and can reveal operational insights much sooner.
Investor Steve Vassallo warns that the biggest danger for newly public tech CEOs is falling into a "quarterly mindset." While they must adopt the discipline of quarterly reporting, obsessing over short-term targets can kill the long-term, ambitious innovation that made the company valuable in the first place.
The convergence of earnings calls on a specific Thursday isn't arbitrary. A former CFO explains it stems from the lengthy internal process of closing books, auditor reviews, and board coordination, forcing companies to report as late as possible within the required window.